Navigation Links
New Stuttering Therapy Scholarship Makes Treatment More Affordable During Tough Economic Times
Date:11/17/2008

The cost of stuttering treatment has become considerably more affordable during this tightened economic environment thanks to a new stuttering therapy scholarship provided by Hollins Communications Research Institute (HCRI).

Roanoke, VA (PRWEB) November 17, 2008 -- The cost of stuttering treatment has become considerably more affordable during this tightened economic environment thanks to a new stuttering therapy scholarship provided by Hollins Communications Research Institute (HCRI -- www.stuttering.org). Founded in 1972, Roanoke, Virginia based HCRI is a world-leading center for the investigation and treatment of stuttering.

Each individual seeking stuttering treatment at HCRI between January, 2008 and May, 2009 will have access to a $1,550 scholarship (based on need) to help offset the cost of therapy. The standard cost of treatment is $4,500, which is priced to meet the nonprofit Institute's actual costs of research and therapy delivery. Yet, by applying the scholarship funds, participants will have a net cost of $2,950 for participation in HCRI's scientifically based program, which has earned acclaim for treatment innovation and therapy results.

HCRI's stuttering therapy, Hollins Fluency Program: Advanced Speech Reconstruction for StutteringTM, helps people who stutter learn how to replace faulty muscle contractions that cause stuttering with new muscle behaviors that generate fluent speech. Treatment consists of 100 clinical hours over a 12-day period and utilizes the latest behavioral, electronic and computer technologies that significantly improve the learning and retention of fluent speech.

The Institute's data shows that 93% of HCRI clients master fluent speech by the end of the stuttering treatment program. Follow-up studies demonstrate 70% to 75% retain fluent speech when evaluated one and two years post therapy.

This new scholarship is made possible through contributions from past HCRI clients who wanted to help other people who stutter experience the same transformational results that HCRI's stuttering therapy program provided to them, according to HCRI Founder and President Ronald L. Webster, Ph.D.

To apply for the scholarship, persons must first complete an application to attend an upcoming HCRI therapy program. An application and more information is available online at www.stuttering.org or by calling 540-265-5650.

About HCRI:
Hollins Communications Research Institute, founded in 1972 by Ronald L. Webster, Ph.D., is a pioneer in the research and treatment of stuttering. The non-profit institute is unique from other stuttering organizations in that work focuses on developing scientifically derived treatment methods, as well as administering stuttering therapy.

More than 5,600 people from 23 countries have come to HCRI for advanced stuttering therapy. Clients include John Stossel of ABC TV's 20/20 program; Annie Glenn, wife of senator and astronaut John Glenn; Lester Hayes of the Oakland Raiders; and Arthur Blank, co-founder of Home Depot and owner of the Atlanta Falcons.

HCRI is located at 7851 Enon Drive, Roanoke, Virginia, 24019. Contact HCRI at admin @ stuttering.org or 540-265-5650. For more information and to view video speech samples, visit www.stuttering.org.

###

Read the full story at http://www.prweb.com/releases/stuttering-therapy/stuttering-treatment/prweb1623394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Is stuttering in our DNA?
2. Help for Stutterers on The Doctors TV Show Presented by Power Stuttering Center Founder Mark Power
3. Study helps clarify role of vitamin D in cancer therapy
4. FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use
5. New Therapy Could Transform Arthritis Treatment
6. Proton therapy may reduce serious side effect of lung cancer treatment
7. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
8. Only Half of MS Patients Respond to Interferon Therapy
9. Game Ready(TM) and ReGear Life Sciences(TM) Bring Innovative New Heat Therapy to Market
10. An ideal therapy for peptic ulcer disease
11. The Neuropathy Associations Scientific Research Grants Focus: Autoimmune and Chemotherapy-Induced Neuropathies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Stuttering Therapy Scholarship Makes Treatment More Affordable During Tough Economic Times
(Date:2/19/2017)... ... 2017 , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively ... any logo with a glitch reveal in just a few clicks of a mouse. Customizable ... of each preset. Use these presets to add a uniquely animated logo to any photos ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... ... 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, +1 ... Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical procedure ... been centered around that idea that to achieve ones desired results a surgical ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... South Africa , Feb. 20, 2017  There ... illness and non-communicable diseases (NCDs) across sub-Saharan Africa, which ... drugs. The growing incidence of more Western lifestyle diseases ... disease, in addition to infectious and parasitic illness, will ... with a business opportunity of $40.8 billion in ...
(Date:2/20/2017)... According to a new market research report "Pulmonary/ Respiratory Drug ... dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications ... to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in ... Continue Reading ... ...
(Date:2/20/2017)... --  Alberty   Drugs , a leading ... has announced a significant shift in focus by concentrating ... servicing local Veteran Affairs Centers (VA) and other Federal ... need to secure cost effective treatments for their patients, ... their goods & services. "The opportunity to ...
Breaking Medicine Technology: